Physician

Mourhaf Traboulssi, M.D.

According to 2025 Medicare claims, Mourhaf Traboulssi, M.D. (NPI: 1639158827) practices cardiology in the Sandusky, OH market, with the plurality of this provider's patient population coming from Erie, OH. This provider's primary affiliated billing organization is UNIVERSITY PRIMARY CARE PRACTICES INC (NPI: 1720220098; TIN: 341768928) and primary practice location at 44870-3390. Traboulssi is affiliated with the University Hospitals Coordinated Care Organization (ACO ID: A1262) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Traboulssi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,850 traditional Medicare patients, billed 4,600 HCPCS/CPT codes, and received $207,346 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,568 prescription claims across 1,473 beneficiaries totaling $1,932,989 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 5 records totaling $36,010. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $305,996 to $207,346. In contrast, Part D prescription costs have moved sharply higher in recent years, from $685,140 to $1,932,989. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,794	6,759	$305,996
2016	2,760	6,544	$303,859
2017	2,660	6,256	$292,956
2018	2,201	5,060	$264,829
2019	2,063	4,780	$262,921
2020	1,817	4,159	$206,879
2021	1,810	3,971	$207,935
2022	2,038	4,729	$232,542
2023	1,871	4,532	$213,125
2024	1,850	4,600	$207,346

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,006	8,401	$685,140
2016	1,054	8,947	$838,630
2017	1,027	8,822	$901,985
2018	1,051	8,669	$973,775
2019	1,099	8,843	$1,056,784
2020	1,094	9,327	$1,204,924
2021	1,138	9,015	$1,217,259
2022	1,203	9,576	$1,526,116
2023	1,245	10,477	$1,857,347
2024	1,473	11,568	$1,932,989

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	614	863	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	233	245	$54
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	428	439	$48
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	445	626	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	577	749	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	884	57,166	$1,080,378
Xarelto	Rivaroxaban	315	23,223	$423,441
Entresto	Sacubitril/Valsartan	51	3,990	$86,848
Jardiance	Empagliflozin	53	3,717	$70,126
Brilinta	Ticagrelor	32	2,419	$34,839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$239	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$35,771	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mourhaf Traboulssi, M.D.?

Tedicare shows public-source Medicare data for Mourhaf Traboulssi, M.D. (NPI 1639158827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mourhaf Traboulssi, M.D. have ACO affiliation data?

Mourhaf Traboulssi, M.D. is shown with ACO affiliation data for University Hospitals Coordinated Care Organization (MSSP, ACO ID A1262) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Mourhaf Traboulssi, M.D.?

Mourhaf Traboulssi, M.D. is linked to UNIVERSITY PRIMARY CARE PRACTICES INC (billing NPI 1720220098) in the available physician profile data.

Does Mourhaf Traboulssi, M.D. have Open Payments data?

Mourhaf Traboulssi, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.